Literature DB >> 20305610

Infection or idiosyncratic reaction to antiepileptic drugs?

Paola Presecki1, Vlado Grosić, Ante Silić, Mate Mihanović.   

Abstract

Idiosyncratic reactions are serious, unpredicted adverse effects of antiepileptic drugs which are in use in psychiatry as mood stabilizers. Severe idiosyncratic reactions can manifest as systemic symptoms or Dress syndrome clinically manifested with increased body temperature, peripheral lymphadenopathy and potential one or multiple organ failure. We present a 36 years old patient, who was hospitalized for the first time in our hospital after he attempted suicide by hanging. Patient was diagnosed as Bipolar affective disorder, current episode depressive with psychotic features and high suicidal risk. At the time of admission he was taking olanzapine and venlafaxine. Psychopharmacs were cross titrated to clozapine, valproic acid and lamotrigine. Two weeks later, patient's mood was stabilized but his somatic status worsened dramatically. He was forwarded to Clinic for Infective Diseases where he was diagnosed with severe sepsis. Dress syndrome, although initially suspected was not verified, but has to be taken into consideration in each patient prescribed with antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305610

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  2 in total

1.  Cases of adverse reaction to psychotropic drugs and possible association with pharmacogenetics.

Authors:  Irina Piatkov; Trudi Jones; Mark McLean
Journal:  J Pers Med       Date:  2012-10-01

2.  Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report.

Authors:  Domenico De Berardis; Michele Fornaro; Laura Orsolini; Luigi Olivieri; Francesco Nappi; Gabriella Rapini; Federica Vellante; Cosimo Napoletano; Nicola Serroni; Massimo Di Giannantonio
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-11-30       Impact factor: 2.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.